Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal fasudil monotherapy in refractory diabetic macular edema
jRCT1031250375Completed
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fasudil in diabetic macular edema (DME). Primary endpoints: visual acuity and retinal foveal thickness. Started Sep 2020; status: completed.
02
Drugs
fasudil
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCT1031250375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250375.